* 为制药公司代工研发、生产药物的中国药明生物2269.HK周三早盘高开3.5%，随后涨幅扩大至4.1%，创2025年10月9日以来新高。
* 该公司稍早公告称，预计2025年净利润同比增46.3%至49.1亿元人民币。
* 药明生物今年迄今涨30.9%，同期恒生指数.HSI上扬6.2%。
* 恒⽣⽣物科技指数.HSBIO盘中一度升1.6%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 杨淑祯)
((kaiwen.xu@thomsonreuters.com))
* 为制药公司代工研发、生产药物的中国药明生物2269.HK周三早盘高开3.5%，随后涨幅扩大至4.1%，创2025年10月9日以来新高。
* 该公司稍早公告称，预计2025年净利润同比增46.3%至49.1亿元人民币。
* 药明生物今年迄今涨30.9%，同期恒生指数.HSI上扬6.2%。
* 恒⽣⽣物科技指数.HSBIO盘中一度升1.6%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 杨淑祯)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.